Health
New drug class effective in treating certain types of ovarian cancers – News-Medical.Net
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in…
A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.
Rucaparib is in a relatively new class of drugs – Poly(ADP-ribose) polymerase or PARP inhibitors – which have been approved for therapy in ovarian cancers. This study provides insights into both how the cancers resist treatments, and which patients…
-
Business23 hours agoDoes Macquarie rate Rio Tinto shares a buy, hold or sell after its big news?
-
Business22 hours agoThese 2 ASX 200 blue-chip stocks just hit new record highs
-
Noosa News23 hours agoLeague blocked trades that didn’t benefit expansion clubs claims former AFLW coach Nathan Burke
-
Noosa News22 hours agoThe ‘architect of modern Queensland’ farewelled in Brisbane